A phase II study of cabozantinib and androgen ablation in patients with hormone-naïve metastatic prostate cancer

Paul G. Corn, Miao Zhang, Graciela M. Nogueras-Gonzalez, Lianchun Xiao, Amado J. Zurita, Sumit K. Subudhi, Shi-Ming Tu, Ana M. Aparicio, Cristian Coarfa, Kimal Rajapakshe, Shixia Huang, Nora M. Navone, Sue Hwa Lin, Guocan Wang, Sumankalai Ramachandran, Mark A. Titus, Theocharis Panaretakis, Gary E Gallick, Eleni Efstathiou, Patricia TroncosoChristopher Logothetis

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of cabozantinib and androgen ablation in patients with hormone-naïve metastatic prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences